The origins of specificity in the microcin-processing protease TldD/E by Gilyarov, Dmitry et al.
ArticleThe Origins of Specificity in theMicrocin-Processing
Protease TldD/EGraphical AbstractHighlightsd E. coli proteins TldD and TldE form a heterodimeric
metalloprotease
d Binding of peptides within the active-site cleft is not
sequence-specific
d Specificity is controlled through the access of substrates via
a narrow channel
d Peptides enter the channel N-terminus first and are
processively digestedGhilarov et al., 2017, Structure 25, 1549–1561
October 3, 2017 ª 2017 The Author(s). Published by Elsevier Ltd
http://dx.doi.org/10.1016/j.str.2017.08.006Authors
Dmitry Ghilarov, Marina Serebryakova,
Clare E.M. Stevenson, ...,






Ghilarov et al. crystallized the microcin-
processing E. coli metalloprotease TldD/
E in complex with various substrates, and
used this structural information to explain
the unusual specificity of the enzyme..
Structure
ArticleThe Origins of Specificity
in the Microcin-Processing Protease TldD/E
Dmitry Ghilarov,1,2,4,8,10,* Marina Serebryakova,2,3 Clare E.M. Stevenson,4 Stephen J. Hearnshaw,4,9 Dmitry S. Volkov,7
Anthony Maxwell,4 David M. Lawson,4 and Konstantin Severinov1,5,6,*
1Centre for Data-Intensive Biomedicine and Biotechnology, Skolkovo Institute of Science and Technology, 143026 Moscow, Russia
2Institute of Gene Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
3Lomonosov Moscow State University, Department of Chemistry, A.N. Belozersky Institute of Physico-Chemical Biology, 119992 Moscow,
Russia
4Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK
5Bionano Institute, Peter the Great Saint Petersburg State Polytechnical University, Saint Petersburg 195251, Russia
6Waksman Institute for Microbiology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
7Lomonosov Moscow State University, Department of Chemistry, Analytical Chemistry Division, 119991 Moscow, Russia
8Present address: Malopolska Center of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland
9Present address: The Institute of Cancer Research, 15 Cotswold Rd, Sutton SM2 5NG, UK
10Lead Contact
*Correspondence: dmitry.gilyarov@uj.edu.pl (D.G.), severik@waksman.rutgers.edu (K.S.)
http://dx.doi.org/10.1016/j.str.2017.08.006SUMMARY
TldD and TldE proteins are involved in the biosyn-
thesis of microcin B17 (MccB17), an Escherichia coli
thiazole/oxazole-modified peptide toxin targeting
DNA gyrase. Using a combination of biochemical
and crystallographic methods we show that E. coli
TldD and TldE interact to form a heterodimeric metal-
loprotease. TldD/E cleaves the N-terminal leader
sequence from the modified MccB17 precursor pep-
tide, to yield mature antibiotic, while it has no effect
on theunmodifiedpeptide.Bothproteins areessential
for the activity; however, only the TldD subunit forms a
novel metal-containing active site within the hollow
coreof theheterodimer.Peptide substratesarebound
in a sequence-independent manner through b sheet
interactionswith TldDandare likely cleaved via a ther-
molysin-type mechanism. We suggest that TldD/E
actsasa ‘‘molecularpencil sharpener’’: unfoldedpoly-
peptides are fed through a narrow channel into the
active site and processively truncated through the
cleavage of short peptides from the N-terminal end.
INTRODUCTION
Escherichia coli microcin B17 (MccB17) is a peptide antibiotic
belonging to the linear azole-modified peptide family of natural
products. MccB17 poisons E. coli DNA gyrase, ultimately lead-
ing to the accumulation of double-stranded DNA breaks and
cell death (Heddle et al., 2001). MccB17 production and immu-
nity require the mcbABCDEFG gene cluster (Genilloud et al.,
1989) (Figure 1A). The mcbA gene encodes the 69-amino-acid
long MccB17 precursor peptide, consisting of the leader and
core parts; the latter part is subjected to post-translational modi-
fication by the McbBCD synthetase complex. The 26-amino-Structure 25, 1549–1561, Octo
This is an open access article undacid N-terminal leader peptide (McbA 1–26) serves as a recogni-
tion element for the binding of the synthetase complex (Roy
et al., 1998; Sinha Roy et al., 1999). In the course of modification,
all cysteine and most serine residues of the core peptide are
converted to thiazole and oxazole heterocycles, yielding pro-
MccB17 (Li et al., 1996). Most MccB17 molecules produced
by cells harboring the mcbABCDEFG cluster contain eight
(four oxazole and four thiazole) heterocycles and an ester
bond, connecting residues Ser52 and Asp53 (MccB17 D8) (Ghi-
larov et al., 2011). Under the conditions of high expression of
mcbBCD, an over-modified form of MccB17 containing an oxa-
zole cycle at Ser52 (MccB17 D9) is also detected (Ghilarov et al.,
2011; Sinha Roy et al., 1999). The last step inMccB17maturation
is removal of the leader peptide yielding mature MccB17, which
is exported from the producing cell by the products of mcbE
and mcbF genes (Garrido et al., 1988).
A screen for mutants abolishing MccB17 production identi-
fied TldE (PmbA) as a protein required for the cleavage of the
MccB17 leader peptide (Rodriguez-Sainz et al., 1990). Allali
et al. (2002) have presented in vivo data showing that tldD, a pa-
ralog of tldE, is also involved in MccB17 maturation. E. coli tldE
and tldDwere independently identified in several screens for mu-
tants resistant to CcdB (LetD), an F-plasmid encoded toxin of the
ccdAB toxin/antitoxin system (Murayama et al., 1996). CcdB
inhibits DNA gyrase, and its toxicity is prevented by the binding
of the CcdA antitoxin (Bahassi et al., 1999; De Jonge et al., 2009;
Maki et al., 1992; Miki et al., 1984). The CcdA41 polypeptide,
consisting of 41 C-terminal amino acids of CcdA, retains the abil-
ity to interact with CcdB and also prevents its cytotoxic activity
(Bernard and Couturier, 1991). Mutations in tldD or tldE make
cells more resistant to CcdB by affecting the stability of
CcdA41 and, possibly, of CcdA (Allali et al., 2002).
Both tldD and tldE genes are common in prokaryotes, with
60% of bacterial genomes and almost all archaeal genomes en-
coding homologs of these twogenes (Allali et al., 2002). The func-
tion of these highly conserved genes remains elusive. Compara-
tive genomic analysis shows that tld genes are frequently located
near lon, a gene that encodes an ATP-dependent protease,ber 3, 2017 ª 2017 The Author(s). Published by Elsevier Ltd. 1549
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Tld Proteins Are Required for MccB17 Production In Vivo
(A) An overview of MccB17 biosynthesis. The gene cluster mcbABCDEFG is annotated according to recommended nomenclature (Arnison et al., 2013). The
leader peptide is shown in magenta and the core part in black, with the heterocyclizable residues highlighted in red. Ser52, which forms an ester bond, is
highlighted in blue and marked with blue asterisk.
(B) The accumulation of unprocessed heterocyclized MccB17 in tld- cells and surrounding agar by whole-cell MALDI-MS imaging (top and bottom spectra,
respectively). Equal quantities of cell material and agar were used and all samples were spiked with equal amounts of human insulin (ins) to serve as an internal
reference. Full-size heterocyclized MccB17 precursor (pro-McbA D8-9, m/z = 5,832–5,852, reflecting different numbers of heterocycles formed) and the mature
MccB17 (m/z = 3,094) are shown.
(C) Tld deletion leads to the impaired export of active compound and accumulation of toxic heterocyclized MccB17 precursor inside the cells. Left: zones of
bacterial growth inhibition on a soft agar inoculated with sensitive E. coli cells and used to overlay colonies of MccB17 producing wt and tld- E. coli strains
(BW25113 pBAD-mcbABCDEFG). Right: SOS response visualized inwt and tld- sfiA::lacZ reporter strains, transformed by pBAD-mcbABCDEFG and grown on a
MacConkey agar plate under inducing (1 mM arabinose) and non-inducing conditions. For clarity, only one of two identically inoculated plates is labeled.which, in E. coli, is involved in CcdA and CcdA41 degradation
(Van Melderen et al., 1994; Van Melderen et al., 1996).
To date, structural information has only been available for
the TldE protein, with four representative structures from Ther-
motoga maritima (PDB: 1VL4; Rife et al., 2005), Pseudomonas
aeruginosa (PDB: 3QTD), Shigella flexneri (PDB: 3TV9), and Bac-
teroides thetaiotaomicron (PDB: 1VPB). All these proteins form
roughly spherical homodimers with a hollow core and none pos-
sesses any recognizable catalytic site or shows biological activ-
ity. Given the relatedness between the sequences of TldD and
TldE proteins, they are expected to share essentially the same
fold, although TldD is distinct in that it contains a conservedmet-
alloprotease-like HExxxH sequence motif that may be involved
in catalysis (Hu et al., 2012).
In this work, we show that E. coli TldD and TldE interact
to form a catalytically active metalloprotease capable of de-
grading unfolded peptides, including modified pro-MccB17
and CcdA41. By contrast, TldD/E is unable to process unmodi-
fied microcin B17 precursor peptide. In tld cells, large amounts
of modified MccB17 precursor accumulate, indicating that
leader peptide cleavage is necessary for toxin export. We pre-
sent crystal structures of TldD/E protease alone and in complex1550 Structure 25, 1549–1561, October 3, 2017with peptide substrates and inhibitors. These reveal that the het-
erodimer forms a spherical shell around a central cavity, analo-
gous to the TldE homodimers reported previously, and that the
conserved HExxxHmotif in TldD does indeed coordinate ametal
ion via the two His residues, together with an additional
conserved Cys residue located near the C terminus. The sub-
strate peptides are bound in an active site cleft on the inner
surface of the TldD subunit, in a sequence-independent fashion
via b sheet interactions. Based on structural superpositions with
thermolysin we propose a metal-dependent proteolytic mecha-
nism for TldD/E. Substrate access is via a narrow pore through
the protein shell that leads directly into the active site. We hy-
pothesize that the TldD/E substrate specificity is conferred by
the size of the pore opening which restricts access to unfolded
polypeptides only.
RESULTS
Both TldD and TldE Are Required for MccB17 Leader
Peptide Cleavage In Vivo
Previous reports (Allali et al., 2002; Rodriguez-Sainz et al., 1990)
provide only limited data on the fate of MccB17 precursor inside
Figure 2. TldD/E Cleaves Modified Microcin B17 Precursor In Vitro
(A) TldDE activity converts heterocyclized MccB17 precursor to the mature MccB17 molecule. Top: mass spectrum of nine-cycle containing heterocyclized
MccB17 precursor (SGSH-pro-McbA D9); insert: mass spectrum showing introduction of nine heterocycles by MccB17 synthetase activity. Bottom: addition of
TldD and TldE leads to the immediate disappearance ofD9mass peak and accumulation of 3,094 DaMccB17 product. In an insert: further cleavage of two amino
acids (Val-Gly) from the N terminus of 3,094 Da MccB17.
(B) Non-heterocyclized SGSH-pro-MccB17 precursor peptide (6,282 Da, top) is stable after overnight treatment with TldD/E (bottom).the tld mutant cells. To get a clearer picture, we analyzed
the TldD/E-dependent processing of MccB17 in vivo by
MALDI-MS imaging of colonies of E. coli BW25113 cells trans-
formed by plasmid pBAD-mcbABCDEFG expressingmcb genes
from an inducible araBAD promoter. MALDI-TOF spectra of
induced wild-type BW25113 and DtldE, andDtldDEmutant cells
transformed with pBAD-mcbABCDEFG differed dramatically
(Figure 1B). Wild-type cells accumulated mature MccB17 D8
(m/z = 3,094 Da [M + H]+) and small amounts of MccB17 precur-
sor with eight heterocycles (pro-MccB17 D8, m/z = 5,852 Da
[M + H]+). In all mutant cells, hyper-modified pro-MccB17 D9
(m/z = 5,832 Da [M + H]+) MccB17 precursor was present.
When the agar around cell colonies was analyzed, a very intense
signal of mature (m/z = 3,094 Da [M +H]+)MccB17was detected
for wild-type, but not tld mutants (Figure 1B, bottom). Consis-
tently, a dramatic decrease in the size of growth inhibition zones
around colonies of tld mutants (compared with the wild-type)
was observed, as previously reported (Figure 1C, left) (Rodri-
guez-Sainz et al., 1990). When a sfiATlacZ reporter strain and
its tld derivatives (Allali et al., 2002) were transformed with
pBAD-mcbABCDEFG and induced with arabinose, tld strains
underwent SOS response, caused by the intracellular accumula-
tion of pro-MccB17 D9 (Figure 1C, right) (Allali et al., 2002).
Purified TldD/E Cleaves Modified MccB17 Precursor
and Other Substrates In Vitro
N-Terminally 6xHis-tagged E. coli TldD and TldE proteins were
separately purified by nickel affinity chromatography (see the
STAR Methods). The expressed protein products had expected
sizes on SDS gels (50.5 kDa for His-TldE and 53.5 kDa for His-
TldD, respectively; see Figure S1A). Proteins were tested for
their ability to cleave the likely substrate, SGSH-pro-MccB17 D9
(m/z=6,202 [M+H]+, averagemass). The substratewasobtained
in vitro by overnight treatment of the recombinant SGSH-McbA
peptide with in vitro reconstituted recombinant MccB17 synthe-
tase (Figure 2A, top, insert) (see the STAR Methods for more de-tails). A 2-hr incubation with either TldD or TldE alone did not alter
the substrate. In contrast, the addition of both proteins together
led to rapid disappearance of the 6,202 Da mass peak and accu-
mulation of a 3,074 Da [M + H]+ product, which corresponds to
mature MccB17 D9 produced by cleavage of the precursor be-
tween residues 26 and 27 (Figure 2A). At longer incubation times,
a 2,918 Da [M + H]+ peak was also observed, corresponding
to the MccB17 D9 variant lacking the first two residues from
the N terminus (Val-Gly) (Figure 2A, bottom, insert). The purified
TldD/E cleavage substrate SGSH-pro-MccB17 D9 is biologically
inactive, presumably because it cannot be transported inside
the susceptible cells, while TldD/E cleavage of SGSH-pro-
MccB17 D9 produced active toxin (data not shown).
A mass peak corresponding to the leader peptide (MccB17
1–26) was absent from mass spectra of TldD/E reactions, prob-
ably due to extensive proteolysis. Indeed, purified MccB17 1–26
peptide (3,143 Da [M + H]+) was rapidly degraded by TldD/E (not
shown). In contrast, when unmodified McbA precursor peptide
was used, no cleavage was observed, either at the leader-core
peptide junction site or within the leader peptide (Figure 2B).
We conclude that TldD and TldE together act as a peptidase
that processes the modified, but not the unmodified, McbA
precursor. The negative result with unmodified precursor sug-
gests that introduction of heterocycles changes the structure
of McbA, unmasking cleavage sites in the leader and at the
leader-core junction.
We also checked the ability of TldD/E to cleave its two other
likely substrates, CcdA and CcdA41. Full-length SGS-CcdA
was stable in the presence of TldD/E in vitro (Figure S2A), but
SGS-CcdA41 was readily degraded to small peptides (Fig-
ure S2B). CcdA41 is an intrinsically disordered C-terminal tail
of CcdA, and previous studies have shown that it is more sus-
ceptible to cleavage by Lon protease compared with the full-
length protein, presumably due to the lack of interactions with
N-terminal folded domain (Burger et al., 2017; Van Melderen
et al., 1996). Hence our results support earlier western blotStructure 25, 1549–1561, October 3, 2017 1551
Table 1. X-Ray Data Collection and Processing Statistics for TldD/E
Dataseta WT-PO4 WT-DRVY WT-HPF WT-Act E263A-hex H262A-pent
Beamline I04-1 I03 I03 I02 I04-1 I04-1
Wavelength (Å) 0.9200 0.9795 0.9763 0.9795 0.9282 0.9282















Space group P21 P21 P21 P21 P21 P21






































136,171 (7,370) 500,650 (36,869) 349,069 (25,341) 287,508 (21,061) 403,735 (28,973) 346,357 (25,317)
Multiplicityb 4.2 (3.0) 6.7 (6.2) 6.9 (6.8) 6.8 (6.7) 6.9 (6.9) 6.8 (6.5)
Mean I/s(I)b 12.3 (2.0) 8.5 (1.0) 9.6 (1.7) 10.1 (1.4) 17.0 (1.2) 11.9 (1.2)
Completeness (%)b 94.1 (69.1) 99.9 (99.7) 97.7 (95.6) 99.8 (99.2) 97.7 (94.6) 99.0 (98.0)
Rmerge
b,c 0.087 (0.551) 0.134 (1.884) 0.115 (1.125) 0.133 (1.344) 0.067 (1.623) 0.084 (1.543)
Rmeas
b,d 0.100 (0.683) 0.145 (2.057) 0.124 (1.217) 0.144 (1.457) 0.073 (1.755) 0.091 (1.677)
CC½
b,e 0.997 (0.565) 0.998 (0.296) 0.997 (0.470) 0.997 (0.453) 0.999 (0.429) 0.998 (0.440)
Wilson B value (Å2) 18.2 9.1 12.1 10.1 13.6 15.3
aWe have used a two-part dataset naming convention comprising the TldD variant type (WT, wild-type), plus a shorthand for the ligand bound at the
active site, where PO4, phosphate; DRVY and HPF, sequences of angiotensin fragments; Act, actinonin; hex and pent, adventitiously bound hexa- and
pentapeptides. N.B.: details of the H262A-pent structure are found in Figure S7.
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iIi(hkl), where Ii(hkl) is the ith observation of reflection hkl, hI(hkl)i is the weighted average
intensity for all observations i of reflection hkl and N is the number of observations of reflection hkl.
eCC½ is the correlation coefficient between symmetry-related intensities taken from random halves of the dataset.data showing stabilization of Ccd41 in tld mutants (Allali
et al., 2002).
To find additional substrates, we tested TldD/E against a panel
of synthetic peptides that are commonly used as MALDI calibra-
tion standards. The results are represented in Table S1 and Fig-
ure S1B. Most peptides were rapidly degraded; however, some
remained intact even after overnight incubation with TldD/E. As
with pro-MccB17, protease activity was manifested only in the
presence of both TldD and TldE proteins. Analysis of proteolytic
fragments gave no clear evidence for preferred sites of cleavage
by TldD/E. The ability of TldD/E to cleave large proteins was
tested using casein and native, reduced, and alkylated BSA,
but no proteolytic activity was observed.
TldD and TldE Form a Stable Complex
Having observed that E. coli TldD and TldE exhibit proteolytic ac-
tivity in vitro only when present together, we analyzed the ability
of these proteins to form a complex. During non-denaturing
PAGE, TldD and TldE each migrate as sharp bands with distinct
mobilities (Figure S3A). When the two proteins are combined
together, a new lower mobility band appears. The analysis of
the protein content of the native gel bands by SDS-PAGE (Fig-
ure S3A) showed that the shifted band consists of an apparently
equimolar mixture of TldD and TldE, suggesting that the two pro-
teins form a complex. Indeed, TldE was co-purified with TldD1552 Structure 25, 1549–1561, October 3, 2017during affinity chromatography of extracts of cells co-overpro-
ducingHis-tagged TldD and untagged TldE (Figure S3B); this pu-
rified complex produced a single peak during gel-filtration chro-
matography (Figure S3C). We used sedimentation equilibrium
analytical ultracentrifugation (AUC) to measure apparent molec-
ular weights of TldD, TldE, or of co-purified complex. In each
case, only sedimenting species corresponding to protein dimers
were detected (observed molecular weights: TldD, 115 kDa;
TldE, 134 kDa; and TldD/E, 124 kDa). We therefore conclude
that TldD and TldE can form both homo- and heterodimers.
The Crystal Structure of TldD/E
The structure of the purified TldD/E protein complex was solved
from a 1.9-Å resolution dataset (WT-PO4, Tables 1 and 2) using
molecular replacement with templates based on structures
that were 23% and 99% identical in sequence to TldD and
TldE, respectively, to give two copies of the TldD/E heterodimer
in the asymmetric unit. These are roughly spherical, resembling
the previously crystallized TldE (PmbA) homodimers, with an
average outer diameter of approximately 65 Å and a hollow
core (Figures 3A and 3B). The sequence of E. coli TldE differs
by only two amino acids from that of Shigella flexneri PmbA,
and thus the E. coli TldE monomer superposes well upon a
monomer from the S. flexneri PmbA homodimer (PDB: 3TV9;
root-mean-square deviation [RMSD] = 0.84 Å). As described
Table 2. Refinement Statistics for TldD/E Structures

















129,447/6,723 475,619/25,030 331,643/17,425 273,176/14,330 383,738/19,995 328,992/17,364
Final Rwork
a,c 0.139 (0.194) 0.149 (0.239) 0.130 (0.179) 0.130 (0.171) 0.145 (0.231) 0.138 (0.234)
Final Rfree
a,c 0.178 (0.248) 0.182 (0.292) 0.171 (0.292) 0.169 (0.269) 0.183 (0.300) 0.171 (0.293)
Estimated coordinate
error (Å)d
0.026 0.009 0.012 0.014 0.011 0.012
RMSD
Bond (Å) 0.010 0.011 0.009 0.009 0.010 0.010
Angle () 1.38 1.52 1.40 1.39 1.38 1.35
No. of protein residues


























No. of heterogen residues:
Zn/ligand/water/otherf
2/2/1,797/12 2/8/2,060/18 2/6/2,093/18 2/2/2,124/11 2/12/2,086/18 2/10/1,973/24


















97.9/2.1/0.0 98.0/2.0/0.0 98.5/1.5/0.0 98.0/2.0/0.0 98.1/1.8/0.1 98.1/1.7/0.2
PDB accession code 5NJ5 5NJ9 5NJA 5NJB 5NJC 5NJF
WT-DRVY peptide ligand was refined with occupancy of 0.7. H262A-pent peptide ligand was refined with occupancy of 0.5.
aValues for the outer-resolution shell are given in parentheses. RMSD, root-mean-square deviation.
bThe dataset was split into ‘‘working’’ and ‘‘free’’ sets consisting of 95% and 5% of the data, respectively. The free set was not used for refinement.
cThe R factors Rwork and Rfree are calculated as follows: R =
P
(j Fobs Fcalc j)/
Pj Fobs j, where Fobs and Fcalc are the observed and calculated structure
factor amplitudes, respectively.
dBased on Rfree as calculated by REFMAC5 (Murshudov et al., 1997).
eThe asymmetric contains two copies of the TldD/E heterodimer where chains A and C are TldD subunits, and B and D are TldE subunits.
f‘‘Other’’ includes ethylene glycol, MES buffer, and sodium ions.
gAs calculated using MolProbity (Davis et al., 2007).for Thermotogamaritima PmbA (PDB: 1VL4; Rife et al., 2005), the
subunit is divided into two domains, each accounting for roughly
half of the primary sequence. The N-terminal domain is pseudo
2-fold symmetric, being comprised of a very long and curved
six-stranded anti-parallel b sheet with a pair of a helices at
each end lying against the convex outer surface of the sheet.
The C-terminal domain is made up largely of b strands, which
are arranged into a five-stranded anti-parallel b barrel and a
six-stranded, mainly anti-parallel, b sheet, which together form
a funnel-shaped structure that wraps around a central a helix,
although one face of the latter is exposed to the inner cavity of
the heterodimer (Figure 3C). Despite only 18% identity between
E. coli TldD and TldE, they share essentially the same fold with an
overall RMSD of 2.53 Å (for 392 aligned residues) (Figure 3D).
However, there are two notable insertions in the C-terminal
domain of TldD giving rise to additional structural elements
(see Figures 3, S4, and S5). One of these, which we term the
‘‘clamp’’ (residues 450–463), lengthens an outer strand of the
six-stranded b sheet observed in TldE and adds an additional
strand, giving a b hairpin that extends the sheet toward the lipof the b barrel, to leave only a narrow gap between the two mo-
tifs. The clamp is partly stabilized by the second insertion, which
we call the ‘‘brace’’ (residues 351–361), that provides support
against the inner surface of the N-terminal domain. Together,
the clamp and the brace extend the ‘‘b funnel’’ to effectively
enclose the central helix, with the exception of the narrow cleft
that remains between the edge of the b sheet and the lip of the
b barrel. Remarkably, apart from the four deposited TldE
(PmbA) structures, there are no other proteins within the PDB
that share any recognizable structural similarity to E. coli TldD
or TldE.
TldD/E Is a Metalloprotease Requiring Fe or Zn as Co-
factors
Multiple sequence alignments against non-redundant sets of
diverged but homologous sequences of TldD and TldE reveal
(Figure S6, see also Hu et al., 2012) a strictly conserved putative
zinc binding motif (HExxxH) in the TldD sequence. An identical
motif is found in dipeptidylpeptidase III (DPP) (Baral et al.,
2008) and a similar motif (HExxH) is present in thermolysinStructure 25, 1549–1561, October 3, 2017 1553
Figure 3. Overall Structure of the TldD/E
Heterodimer
(A and B) Orthogonal views of the TldD/E hetero-
dimer shown in cartoon representation with TldD in
slate blue and TldE in maroon; the non-crystallo-
graphic 2-fold axis is vertical in (A) and perpendic-
ular to the plane of the image in (B). The catalytic
zinc associated with TldD is represented by the
cyan sphere and a bound peptide by the b strand in
magenta. The putative substrate entrance channel
is marked by an asterisk in (A); access through this
channel may be mediated by the insert marked in
yellow, which we describe as the ‘‘plug.’’
(C and D) Corresponding views of TldE and TldD
subunits alone, as seen from the interior of the
heterodimer, highlighting their similarities and dif-
ferences. For each, the N-terminal domain is shown
in green and the C-terminal domain in yellow.
Within the latter, the central helical region (which
includes the HExxxH motif in TldD) is highlighted in
red. The black spheres in TldE indicate the
approximate positions at which insertions arise to
give the clamp and brace motifs shown in TldD;
again the zinc is represented by the cyan sphere
and a bound peptide by the magenta b strand.
(E and F) Equivalent views to (C and D), but with the
protein shown as a molecular surface and the
bound peptide in stick representation withmagenta
carbon atoms; again the putative substrate
entrance channel is marked by an asterisk.and matrix metalloproteases (MMPs) (Cerda-Costa and Gomis-
Ruth, 2014; Holden and Matthews, 1988). We have measured
the metal content of purified His-tagged TldD and TldE by
inductively coupled plasma atomic emission spectroscopy
(ICP-AES). In this technique, diluted protein solutions are vapor-
ized and injected in a stream of plasma to produce radiation sig-
natures specific for different elements. While TldE contained no
metal ions, recombinant TldD contained roughly equal amounts
of iron and zinc; the total metal content was approximately one
mole of metal permole of TldDmonomer. To determine which of
the two metal ions was required for enzymatic activity, we have
grown TldD-overproducing cells on M9 minimal medium sup-
plemented with 50 mM of zinc or iron salts. TldD purified from1554 Structure 25, 1549–1561, October 3, 2017these cells contained, correspondingly,
>95% zinc or >80% iron as measured
by the ICP-AES. When the activity of
these enzymes was measured, no differ-
ence was observed. We have checked
the ability of EDTA, O-phenanthroline
(OP), and several readily available metal-
loprotease inhibitors to block TldD/E
action, using angiotensin II (Asp-Arg-
Val-Tyr-Ile-His-Pro-Phe) as a test sub-
strate (Table S3). OP and natural product
actinonin (deformylase inhibitor) effi-
ciently prevented angiotensin II hydroly-
sis by TldD/E. Interestingly, EDTA was
ineffective at preventing hydrolysis even
at high (100 mM) concentration; as were
phosphoramidon and bestatin. Actinoninwas therefore used to produce a co-complex structure with
TldD/E (see below). The observed difference in reactivity be-
tween two metal chelators, EDTA and OP, is not unusual and
can be explained by fast formation of an inhibitory ternary OP-
metal-protein complex (Kleemann et al., 1986; Massaoud
et al., 2011; Mayaux et al., 1982; Vallee and Hoch, 1957). In
contrast, EDTA, a bulky ligand, primarily acts as metal ion scav-
enger (by chelating free metal ions in solution and thus slowly
shifting the equilibrium toward apoenzyme); therefore, an
enzyme with a sufficiently low metal dissociation constant is
not inactivated. Indeed, we have found that removal of metal
from TldD occurs very slowly and requires several rounds of
dialysis against 10 mM OP to be complete. The enzymatic
Figure 4. Comparison of the TldD Active
Site with Thermolysin and Proposed Cata-
lytic Mechanism
(A) Close-up of the TldD active site showing key
residues and a bound phosphate oxyanion su-
perposed on a 1.9-Å resolution omit electron
density map for the latter (contoured at 5s).
(B) Corresponding key residues taken from a
representative thermolysin structure in the equiv-
alent orientation to TldD shown in (A). Note the
distortion of the helix in TldD resulting from the
additional residue in the zinc binding motif.
(C) Proposed promoted-water mechanism for
TldD. (1) Situation prior to substrate binding with
catalytic water bound to zinc and hydrogen
bonded to the acid-base catalyst Glu263. The ex-
pected position of the water would overlap one of
the phosphate oxygens shown in (A) (labeled with
an asterisk). (2) The substrate is bound in the active
site with the carbonyl oxygen of the scissile bond
forming a fifth zinc ligand. Glu263 deprotonates
the water molecule and the resultant hydroxide
ion performs a nucleophilic attack on the carbonyl
carbon. (3) The tetrahedral intermediate (mimicked
by the phosphate complex) (A) breaks down as a
result of protonation of the amide of the leaving
group. (4) Situation post-reaction prior to dissoci-
ation of the products. For clarity, an interaction
between Gly455 and the catalytic water is not
shown in this scheme.activity of the resultant apoenzyme can then be reconstituted by
adding metal.
In the TldD/E structure, the TldD HExxxH motif, spanning
residues 262–267, is located on the central helix that resides
within the b funnel, and with the two histidine residues,
His262 and His267, coordinating a metal ion, which we
modeled as Zn (because Zn was added to the growth medium)
(Figures 4A and S8); a third ligand is provided by Cys454 from
the clamp domain. None of these residues are conserved in
TldE, consistent with it being catalytically inactive. We have
constructed His262 and His267 alanine substitution mutants,
of which His267Ala was not folded correctly and His262Ala
was catalytically inactive but, surprisingly, had wild-type
Zn/Fe content as determined by ICP-AES. To rationalize this
observation, we solved the structure of the mutant TldDH262A/E
complex (Figure S7 and description), which revealed that the
carboxylate group of the neighboring Glu263 replaces the
missing imidazole moiety of residue 262 as the third TldD Zn
ligand.StrucWith the exception of the zinc binding
motif, TldD and thermolysin share no
obvious sequence or structural similarity
(Matthews et al., 1972). However, it is
possible to manually superpose the
active site of TldD onto that of thermoly-
sin such that the zinc ion and its liganding
residues overlap closely; the only signifi-
cant difference being that Cys454 of
TldD serves as ligand in place of Glu166
in thermolysin (Figures 4A and 4B). Interms of the metal coordinating residues, TldD is even more
akin to peptide deformylase, which also has a Cys as the third
ligand (Chan et al., 1997). Despite their dissimilar folds, the zinc
binding motifs of thermolysin and TldD, both lie in helical re-
gions of their respective proteins, and these become aligned
as a result of the above superposition. TldD accommodates
the extra residue of its HExxxH motif (compared with HExxH
of thermolysin) within a single helical turn between the two
His residues, leading to a distortion of the helical geometry,
similar to one observed in DPP; however, the observed distor-
tion is even more pronounced in the case of TldD. By contrast,
this distortion is not seen in the equivalent region of TldE.
Importantly, our superposition also aligns Glu263 of TldD with
Glu143 of thermolysin, which acts as an acid-base catalyst in
the latter. In our first determined structure of TldD/E, a phos-
phate anion (derived from the crystallization solution, hence
WT-PO4) serves as a fourth ligand to the zinc, which is also
held by a bidentate interaction with Glu263. An oxygen atom
of this bound phosphate corresponds to the position of theture 25, 1549–1561, October 3, 2017 1555
‘‘catalytic’’ water molecule in thermolysin (Figures 4A and 4B).
Taken together, these structural correlations allow us to pro-
pose a promoted-water mechanism (Xu and Guo, 2009) for
TldD based on the wealth of data available for thermolysin
and MMPs (Bertini et al., 2006; Cerda-Costa and Gomis-
Ruth, 2014; Inouye et al., 2007) (Figure 4C). In the absence of
adventitiously bound ligands, we expect the fourth zinc coordi-
nation site of TldD to be occupied by a water molecule. The
carbonyl oxygen of an incoming substrate becomes a fifth
zinc ligand, and the carbonyl carbon is then subject to nucleo-
philic attack by a hydroxide ion generated through Glu263-
mediated deprotonation of the water molecule. The resultant
negatively charged tetrahedral intermediate is stabilized
through interactions with the zinc; this stage of the reaction is
mimicked by the phosphate-bound TldD/E structure. The sub-
sequent decomposition of the tetrahedral intermediate is initi-
ated by Glu263-mediated protonation of the amide leaving
group using the proton previously abstracted from the nucleo-
philic water (Figure 4C). Additional functional roles could be
ascribed to the main-chain nitrogen of Gly455 (which overlaps
with Nε2 of His231 in thermolysin) in binding the catalytic water
and in stabilizing the tetrahedral intermediate, and to the
carbonyl group of Gly394 (which overlaps with the carbonyl of
Ala113 in thermolysin) in substrate binding and partial charge
stabilization through hydrogen bonding to the amide nitrogen
of the scissile bond (Figures 4A and 4B).
The Substrate Binding Cleft of TldD/E Does Not Impose
Specificity Constraints
To explore the substrate binding site of the TldD/E heterodimer,
wild-type or mutant (Glu263Ala) TldD/E was co-crystallized with
a variety of peptides and peptide mimics, leading to four distinct
ligand-bound complexes. Wild-type TldD/E crystals were grown
in the presence of the peptide angiotensin II (Table S1), and
customized angiotensin II variant where the central (Tyr-Ile) pep-
tide bond is replaced with a non-cleavable methylene bond, to
yield two co-crystal structures with clear density for peptides
where the carboxyl group of the C-terminal residue acts as a
ligand to the catalytic zinc ion. In the case of angiotensin II, the
density was consistent with Asp-Arg-Val-Tyr (hence WT-DRVY;
Tables 1 and 2; Figure 5A), indicative of cleavage at the central
peptide bond of angiotensin. However, the methylene bond
variant gave density for a His-Pro-Phe peptide, i.e., the C-termi-
nal portion of the added compound (hence WT-HPF; Tables 1
and 2; Figure 5B); it was not clear whether the lack of clear den-
sity N-terminal to the His residue was due to a cleavage event, or
simply that this region of the peptide was disordered. Using the
standard nomenclature for protease active sites (Schechter and
Berger, 1967), these two ligands spanned subsites S4-S1 and
S3-S1, respectively, occupying roughly half of the active site
cleft. By contrast, a wild-type crystal grown in the presence of
the antibacterial agent actinonin (WT-Act; Tables 1 and 2) gave
unambiguous density for the ligand in the other half of the active
site cleft, chelating the zinc via its hydroxamate group, with the
rest of the ligand mimicking a tripeptide spanning subsites
S10-S30 (Figure 5C).
Attempts were made to trap uncleaved peptides in the active
site of TldD through the use of a catalytically inactive Glu263Ala
mutant. Surprisingly, the resultant density was essentially the1556 Structure 25, 1549–1561, October 3, 2017same in every case, irrespective of the added ligand. We there-
fore focused on the highest resolution dataset, which had been
collected to 1.45-Å resolution after co-crystallization with the en-
gineered angiotensin variant described above. Clear density was
present for the backbone of a hexapeptide spanning subsites
S3-S3’ (hence E263A-hex; Tables 1 and 2) and, for four of the
residues, probable identities could be assigned based on side-
chain density to give an x-Leu-x-Asp-Arg-Ile sequence (Figures
5D and 5E). This bore no resemblance to any of the added
ligands, but curiously gave a match with residues 49–54 of
TldD itself (see Figure S3). A possible explanation for this could
be that proteolytic fragments of the overexpressed TldD protein
are comparatively abundant in the expression host, and this
particular fragment binds with high affinity, principally due to
the Asp residue in subsite S10, the side chain of which does
not occupy the pocket used by the n-pentyl chain of actinonin,
but rather chelates the catalytic zinc.
It is especially apparent in this complex that the ligand binds
in an extended conformation along the length of the active site
cleft. Remarkably, hydrogen bonding is restricted to backbone
atoms only, such that the peptide acts as an additional b strand
that effectively fuses the b sheet and the b barrel motifs in the
C-terminal domain of TldD through anti-parallel interactions
with both supersecondary structural elements that extend from
subsite S2 to S20 inclusive (Figures 5D, 5F, and 3D). Furthermore,
binding of the hexapeptide does not result in any significant
conformational changes. When compared against the phos-
phate-bound structure, the RMSD after superposing TldD Ca
atoms was only 0.33 Å (averaged across both copies of the sub-
unit in the asymmetric unit). While it is not unusual for peptides
to bind to proteins in extended conformations through b sheet in-
teractions, being especially prevalent in the active sites of prote-
ases (Malito et al., 2008; Tyndall et al., 2005), we are not aware of
any other examples where the peptide unites two b-structural
motifs by slotting into a pre-existing gap. The integrity of this cleft
is maintained in part by the aforementioned brace that stabilizes
the clamp against the inner surface of the N-terminal domain.
Furthermore, a number of highly conserved residues play impor-
tant roles. Among these are residues that help to tether the
clamp, such as Cys454 and Lys456, both of which link b23 to
the central helical region, the former via the active site zinc to
His262 and His267 (in the HExxxH motif), and the latter via
salt bridges to Glu270 and Asp272 that are also highly conserved
(Figures S4 and S6). Indeed, alanine substitutions of Glu270 and
Asp272 severely reduced expression of soluble protein (data not
shown), consistent with an important structural role for these
residues. Similarly, Arg362 in the brace provides further stabili-
zation to the clamp via hydrogen bonds to backbone carbonyls
in both b23 and b24.
As a consequence of this mode of binding, TldD has very
relaxed substrate specificity. When all the ligand-bound struc-
tures are superposed, it is apparent that at most subsites, the
peptide side chains either lie across the protein surface or are
pointing away from it. Only the residues at subsites S2 and S10
have their side chains directed toward the bottom of the active
site cleft (Figure 5F). Subsite S2 is a shallow depression delin-
eated by the side chains of Phe273, Val396, Ile398, Lys456,
and His267, and would appear to be well suited to binding small
or medium-sized aliphatic or neutral side chains. Indeed, our
Figure 5. Ligand Complexes of TldD/E
(A–D) Final coordinates of bound ligands shown in the same relative orientation (viewed from the side of the active site cleft) with associated omit electron density
(resolutions and contour levels shown in red) and the active site zinc in cyan for (A) the N-terminal half of the cleaved angiotensin II peptide, (B) the C-terminal end
of the angiotensin variant (the Phe side chain has been modeled in two alternative conformations), (C) the antibacterial agent actinonin (pseudo-residues labeled
in quotes), and (D) the hexapeptide bound to the TldD-E263A mutant.
(E) Detail of the hexapeptide (with omit electron density) in the context of the active site as viewed from above, showing the anti-parallel b sheet interactions that
bind the peptide in the cleft that is highlighted by the semi-transparent molecular surface. The asterisk marks the putative substrate entrance channel.
(F) Overlay of ligands shown in panels (A–D), colored and oriented as indicated in the small insets for these panels. In addition, the phosphate from the original
1.9-Å resolution structure is shown in magenta. The locations of the various subsites are labeled in blue; the blue hatched area indicates where there is scope for
an expanded S2 subsite. The side chains of residues that delineate the subsites S2 and S10 are shown; for clarity, Cys454 (the sulfur would eclipse the Zn in the
current view) and Lys456 (which would be in the foreground providing one face of the P2 subsite) are not shown. The molecular surface is finely sliced to illustrate
the contours of the substrate binding pocket without obscuring detail.structural data indicate that it can accommodate all of Leu, Val,
and Pro (Figure 5F); Leu and Val would also bind here when the
twopossible cleavages aremade in theMccB17precursor. How-
ever, fromMALDI-MS data, it seems that this site is considerably
more promiscuous, with Glu and Trp being accepted among
others. It is possible that these bulkier side chains could be
accommodated in a larger S2 subsite that extends beyond the
lip of this shallow depression. Subsite S10 is more enclosed and
deeper, being bounded by the side chains of His262, Trp256,
Val259, Val463, and Val465 (Figure 5F). Again this would appear
to be well suited to binding small or medium-sized aliphatic or
neutral side chains. In the actinonin structure, the n-pentyl chain
of the ligand projects into the pocket, this being a mimic of a Metside chain. Moreover, for the two observed cleavage sites in the
microcin precursor, Val and Ile would need to bind here. MALDI
data indicate that Lys, Trp, and Glu are also accepted. Perhaps
in this case, the subsite is able to remodel itself to accommodate
these various side chains, e.g., a flipped Trp256 side chain would
provide a significantly greater S10 capacity.
TldD/E Substrate Binding Specificity Is Governed by
Compartmentalization of the Active Site
The active site cleft of TldD/E is open at both ends and, because
of relaxed substrate preferences, any exposed protein terminus
could be a potential substrate. Thus, TldD has the capacity
to wreak proteolytic havoc within the cell, and it is presumablyStructure 25, 1549–1561, October 3, 2017 1557
Figure 6. Substrate Access to the Active Site in TldD/E
A modeled peptide (green carbons) stretching from the active site through the
substrate access channel to the outside surface of the molecule suggests that
an unfolded N-terminal region of at least 15 residues would be necessary in
order observe proteolysis of an otherwise folded protein (assuming that the
first six residues engage with subsites S3-S30 and that a tripeptide is released).
The site of proteolytic cleavage adjacent to the zinc (cyan sphere) is indicated
by the dashed horizontal line. An insertion in the N-terminal domain of TldD
relative to TldE gives rise to the short surface loop highlighted in yellow. The
presence of three acidic residues in this loop and three basic residues
arranged around the mouth of the channel (all labeled) suggests that under
certain conditions the loop may ‘‘plug’’ the channel through the formation of
salt bridges, thereby blocking access to the active site.for this reason that the active site is sequestered within a
protein shell, so that the availability of substrates is significantly
restricted. We do not expect substrates to reach the active site
through transient dissociation of the complex, since TldD/E het-
erodimer is stable during gel filtration and can withstand exten-
sive high-salt washing (see the STAR Methods section). Instead,
we propose that substrate peptides access the active site cleft
by feeding through one of the handful of narrow channels perfo-
rating the outer shell of the heterodimer. The widest of these
passes between the two domains of TldD and leads directly
into the active site cleft, and is therefore the most likely access
route. Given the orientation of the cleft relative to this channel,
substrates entering the N terminus first would be correctly ori-
ented to bind directly into the active site cleft. Thus, the unfolded
N termini would be more likely to serve as substrates than
C termini. It is difficult to envisage a situation where exposed sur-
face loops could engagewith the catalytic site at all. Bymodeling
an extended peptide through the channel to the active site, we
estimate that an unfolded N-terminal region of at least 15 resi-
dues would be necessary to achieve proteolysis of an other-
wise intact globular protein (assuming that the first six residues
engage with subsites S3-S30 and that a tripeptide is released;
Figure 6). Extensive degradation of the N-terminal McbA leader
peptide after TldD/E treatment of modifiedMcbA precursor pep-1558 Structure 25, 1549–1561, October 3, 2017tide thus implies that the leader peptide is threaded through the
channel and serially truncated until the heterocyclized region is
sterically constrained by the entry channel.
While having an active site that is only accessible via a nar-
row channel would certainly restrict the range of potential sub-
strates for TldD, there may be a further mechanism whereby
substrate entry is controlled. In addition to the two inserts in
the TldD sequence relative to TldE mentioned above, there is
a third insertion that resides within the N-terminal domain.
This forms a short loop in TldD that projects from the outer sur-
face of the heterodimer adjacent to the putative substrate ac-
cess channel. The loop contains three acidic residues
(Asp216, Asp218, and Glu220), and there are three basic resi-
dues arranged around the mouth of the channel (Arg232,
Arg305, and Lys446), prompting us to speculate that, under
certain conditions, the loop may act as a ‘‘plug’’ to block the
channel by the formation of up to three salt bridges with the
channel mouth. Nevertheless, the main-chain temperature
factors of the plug are not significantly elevated relative to the
core of the molecule, suggesting that, at least in the crystalline
state, this loop is not especially mobile.
DISCUSSION
With the exception of the four previously determined TldE struc-
tures and each other, E. coli TldD and TldE are not structurally
similar to other known proteins. We show that they assemble
to form a new class of heterodimeric metalloprotease, where
the catalytic metal, which can be zinc or iron, is coordinated by
residues of TldD only, via two His residues from a HExxxH motif
and a remote Cys (residue 454). The proteolytic activity is only
observed when both TldD and TldE are present. This is at odds
with a recent observation that a Sulfolobus solfataricus TldD
homodimer is catalytically active, and with the proposal that
the equivalent of Cys454 is not a metal ligand, but instead forms
a disulfide bridge in the TldD homodimer (Hu et al., 2012). From
sequence comparisons it seems that in some cases Asp can
substitute for Cys as the third metal ligand (e.g., in Gemmatimo-
nas sp.), whichwould not be then capable to form any disulfide at
all. Moreover, this substitution would give a more thermolysin-
like active site, where the third ligand is Glu (Figure 4B).
We demonstrate that E. coli TldD/E cleaves off the N-terminal
leader peptide of pro-MccB17, as well as a number of other pep-
tide substrates. Crystal structures of TldD/E in complex with
different peptide ligands demonstrate a unique binding mode
in which the incoming substrate fits perfectly into a pre-existing
gap between b strands, with hydrogen bonding restricted only to
main-chain atoms. To counterbalance this relaxed specificity,
the active center is enclosed within a spherical shell formed
by the two partner proteins. Only completely unfolded peptides
are allowed entry through a narrow channel leading directly to
the active center cleft, an arrangement that would only support
cleavage at the N terminus of the substrate. Since removal of
the leader sequence is required before MccB17 can be ex-
ported, the inability of TldD/E to digest unmodified MccB17 pre-
cursor peptide ensures that only fully mature toxin is released.
Intriguingly, the idea that MccB17 precursor has some degree
of secondary structure in solution is indirectly supported by the
observed N-C directionality of MccB17 biosynthesis (Kelleher
Figure 7. Dimer Interface in TldD/E
Comparison of (A) E. coli TldD/E heterodimer and
(B) Shigella flexneri TldE/E homodimer interfaces.
In both cases the left hand panel shows amolecular
surface for a TldE monomer viewed from the inte-
rior (oriented and colored as shown in Figures 3E
and 3F). In the right-hand panels the same molec-
ular surface is shown, but colored gray except for
regions buried at the interface with the opposing
subunit, where it is colored dark blue. Displayed
in semi-transparent cartoon representation are
the opposing subunits for each of the assemblies
(colored as shown in Figures 3C and 3D) and, for
TldD, the active site zinc (cyan sphere) and a
bound peptide (magenta arrow) are also shown.
The diagonal dashed lines indicate the approxi-
mate position of the 2-fold axes relating one
subunit to the other. It is clear that the heterodimer
(A) has a significantly more extensive interface than
the homodimer (B), in particular where the b barrels
of the C-terminal domains come together (bottom
right patch; see also PISA analysis in Table S2).et al., 1999; Roy et al., 1999), which can be explained by the
progressive ‘‘unwinding’’ of the precursor peptide along with
the incorporation of heterocycles. It is known that MccB17
biosynthesis (Kelleher et al., 1999) is distributive, meaning that
McbBCD does not hold the substrate all the time. This should
allow TldD/E to start processing as soon as MccB17 precursor
with few heterocycles becomes available, exposing the leader
sequence. This leads to the observed (Ghilarov et al., 2011;
Sinha Roy et al., 1999) in vivo distribution of incompletely
cyclized products exported from the cell.
We assume that one copy of TldD lost its catalytic center and
evolved separately as theTldEprotein. Lacking acatalytic center,
TldE does not form a substrate access channel but instead pro-
vides extra space to accommodate the N termini of peptides,
which potentially contributes to the processivity of the TldD/E
heterodimer that functions as a ‘‘molecular pencil sharpener.’’
One can hypothesize that the two proteins co-evolved to offer
higher stability of the outer shell and tighter regulation of other-
wise promiscuous peptidase. Indeed, as both TldD and TldE
(as judged by AUC) are able to form homodimers, preferential as-
sembly of a heterodimer in the presence of both subunits must
be a consequence of its higher stability. Indeed, analysis of the
TldD/E heterodimer interface with the PISA server (Krissinel,
2015) gives a buried surface area of approximately 2,600 Å2,
compared with 1,900 Å2 calculated for the Shigella flexneri TldE
homodimer (Figure 7; Table S2). The TldD homodimer is not sta-
ble enough to be detected on a non-denaturing gel or to be puri-
fied as a dimer from bacterial cells. Such preferential associationStrucof heterologous subunits allows for a hy-
pothetical activity control mechanism in
which, given a steady-high level of expres-
sion of TldE, even transient expression of
TldDwill lead to formationof activeproteo-
lytic complex. We speculate that TldD is
intrinsically susceptible to cellular prote-
ases in its monomeric form and is rapidly
degraded; this would minimize the poten-tially harmful effects of exposing the promiscuous active site to
multiple possible substrates. Indeed, this might explain the origin
of the hexapeptide we see bound to the Glu263Ala TldD mutant.
The widespread presence of tld genes suggests that they
have an important function in bacterial physiology which might
include, but not be limited to, a role in protein quality control
and in the activation and degradation of different natural prod-
ucts (MccB17), peptide-derived co-factors (Pqq), or toxin-anti-
toxin modules (CcdA). We speculate that the unusual properties
of this novel class of protease, which can be stably expressed
in high yield, could be exploited for future applications in the
protein engineering and synthetic biology fields.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
E. coli DH5a (NEB) was used for all cloning purposes; BL21 (DE3) Gold (Agilent) was used for protein expression. CSH600 sfiA::lacZ
reporter strain and its tld- derivatives were described elsewhere (Allali et al., 2002) and are a gift of Dr. Van Melderen (Laboratoire de
Génétique et Physiologie Bactérienne, Université Libre de Bruxelles, Gosselies, Belgium). BW25113 strain was a gift of Dr. Kirill A.
Datsenko (Department of Biological Sciences, Purdue University, West Lafayette, USA).Structure 25, 1549–1561.e1–e5, October 3, 2017 e2
METHOD DETAILS
Gene Disruptions
BW25113 DtldD and DtldE strains were produced by gene disruptions according to the published protocol (Datsenko and Wanner,
2000) using plasmids pKD4 and pKD46 (gift of Dr. Datsenko) and cleaned from the kan resistance cassettes by using the published
FLP recombination protocol and corresponding plasmid pCP20 (Datsenko and Wanner, 2000) (gift of Dr. Datsenko). tldDE double
deletion strain was obtained by the replacement of tldE gene in the cleaned tldD strain by the kan resistance cassette and its
subsequent elimination.
Cloning and Purification of MBP-tagged Proteins
CcdA andCcdA41 sequences were amplified from the F-plasmid containing XL1-BlueE. coli strain (Agilent) and cloned to the pET28-
MBP plasmid by usingBamHI andNot I restriction sites. A DNA fragment encoding for MccB17 leader peptide (McbA 1-26) was PCR
amplified from pBAD-mcbABCDEFG plasmid and cloned into PET28-MBP by using Bam HI and Not I restriction sites. A full-length
McbA peptide was cloned similarly. For purification of MBP-tagged proteins, 400 ml of BL21 (DE3) Gold, transformed with the
relevant plasmid, were grown in 2YT medium to OD600 = 0.6, then induced with 0.5 mM IPTG and allowed to grow for 3 h at 37
C
(for MBP-McbA, MBP-CcdA, MBP-CcdA41 and MBP-McbA 1-26) or overnight at 22C (for MBP-McbB, C and D). Cells were
harvested by centrifugation at 4000 g, resuspended in MBP lysis buffer (50 mM Tris$HCl pH 7.5, 500 mM NaCl, 2.5% (w/v) glycerol
and 0.1% Triton X-100, 2 mg/ml lysozyme) supplemented with protease inhibitors (Roche) and lysed by sonication. Cleared filtered
lysates were applied to 5 ml MBPTrap column (GE Healthcare) and washed by 20 column volumes (CV) of washing buffer (50 mM
Tris$HCl 7.5, 400 mM NaCl, 2.5% glycerol, 2 mM DTT). Proteins were eluted from the column with elution buffer (50 mM Tris$HCl
pH 7.5, 150 mM NaCl, 5% glycerol, 2 mM DTT, 10 mM maltose), fractions containing the highest concentrations of protein were
aliquoted and frozen in liquid nitrogen.
Cloning, Mutagenesis and Purification of TldD and TldE Proteins
The TldD and TldE gene sequences were amplified from E. coli MG1655 genomic DNA by using Thermo Phusion DNA polymerase
and cloned into pET28 b (Novagen) protein expression vectors by using Nde I and Xho I restriction sites. For the purification, 400 ml
2YT cultures were grown at 37 C to OD600 = 0.5 and induced with 0.5 mM IPTG for 4 h. Cells were subsequently harvested by
centrifugation and resuspended in lysis buffer (20 mM Tris$HCl pH 8, 400 mM NaCl, 10 mM imidazole, 2 mg/ml lysozyme, 1 mM
PMSF, 0.1 % Triton X-100) and lysed by sonication. Proteins were loaded on columns containing 0.5 ml of pre-equilibrated
Ni-NTA resin (Qiagen). Resin was washed with 20 CV of lysis buffer containing 20 mM imidazole (20 mM Tris$HCl pH 8, 400mM
NaCl, 20 mM imidazole) and proteins were eluted with 250 mM imidazole. Purified proteins were dialysed against storage buffer
(20 mM Tris$HCl pH 8.0, 200 mM NaCl, 50% glycerol) and stored at -20C. TldD active site mutants were constructed by
overlapping extension PCR, cloned and produced as described above.
To obtain different combinations of tagged and untagged TldD and TldE proteins for the co-purification experiments, TldD and TldE
genes were cloned into pColA-Duet (Novagen) co-expression plasmid. Cloning to MCS I by using BamHI and HindIII restriction sites
led to the expression of tagged protein, whilst cloning into the second MCS by NdeI and XhoI led to the production of an untagged
protein. For TldD/E pull-down trials, cells were grown, lysed and loaded on a column as described above and washed with 20 CV
of wash buffer [20 mMTris-Cl pH 8, 5% glycerol , 0.1% Triton X-100. 1 M NaCl and 50 mM imidazole] before eluting with 250 mM
imidazole..
In Vitro McbBCD Synthetase and TldD/E Reactions
Reactions with MBP-tagged McbA and McbB, C and D proteins were performed as described before (Lee et al., 2008). Briefly, MBP
tags were removed by 2 h treatment with TEV protease at 30C; this lead to the extra SGS or SGSH sequence on N-termini of
recombinant peptides. The heterocyclized MccB17 precursor was obtained by overnight treatment of 10 mM SGSH-McbA with
an equimolar mixture of BCD proteins (2 mM each) in the reaction buffer (50 mM Tris$HCl pH 7.5, 125 mM NaCl, 20 mM MgCl2,
2 mM ATP, 10 mM DTT). TldD/E was added at 0.3 mM. Reactions were incubated at 37C for 120 mins or overnight. Aliquots
were taken every 30 mins for MALDI analysis and desalted using Zip-Tips C18 (Millipore).
MALDI-MS and MS/MS Analysis
1-ml aliquots of desalted in vitro reaction mixture or0.2 ml of cells growing onM9minimal mediumwere diluted in 10 ml of 0.5% TFA.
1 ml of the diluted sample was mixed with 0.5 ml of 2,5-dihydroxybenzoic acid solution (20 mg/ml in 30% acetonitrile, 0.5% TFA)
and left to dry on the stainless-steel target plate at room temperature. For the measurement of MccB17 in agar around producing
colonies, a small piece of M9 agar was cut and extracted by three volumes of 0.5% TFA for 1 hour then a 1-ml aliquot was used
for measurement. MALDI-TOFMS analysis was performed on UltrafleXtremeMALDI-TOF-TOFmass spectrometer (Bruker Daltonik,
Germany) equipped with Nd laser. The MH+ molecular ions were measured in reflector mode; the accuracy of monoisotopic mass
peak measurement was within 30 ppm. Spectra were acquired by averaging of a minimum 1000 laser shots from ‘‘sweet spots’’ of
matrix crystals. Spectra of fragmentation were obtained in LIFT mode, the accuracy of daughter ions measurement was within 1 Da
range. Mass-spectra were processed with the use of FlexAnalysis 3.2 software (Bruker Daltonik, Germany) and analyzed manually.e3 Structure 25, 1549–1561.e1–e5, October 3, 2017
Metal Content Measurements (ICP-AES)
Purified proteins (0.1 – 0.5 mg/ml) were dialyzed three times against 10 mM Tris$HCl pH 8.0 in deionized (mQ) water in the presence
of 0.5% Chelex-100 (Bio-Rad) to remove trace metal ions from the buffer. An axial ICP-AES 720-ES spectrometer (Agilent Technol-
ogies, USA) was used formeasurements with a low flow axial quartz torch with 2.4mm inner diameter injector tube (Glass Expansion,
Australia), a double-pass glass cyclonic spray chamber (Agilent Technologies), a OneNeb nebulizer (Agilent Technologies, USA), and
a Trident Internal Standard Kit (Glass Expansion). Samples were introduced manually to reduce washing volume, without preliminary
digestion or dilution. A Sc solution (20 ppm) internal standard was added to increase the accuracy of measurements. Results were
collected and processed by ICP Expert software 2.0.5 (Agilent Technologies). An ICP-AM-6 standard solution, 1000 ppm (High Purity
Standards) was used for calibration in the range 10–200 ppb.
Non-denaturing Electrophoresis & AUC
Purified TldD and TldE (see above) at2mg/ml were loaded onto native Tris-Glycine acrylamide gels (0.75mm, 7%) and run at 150 V.
To assess complex formation, TldD and TldE proteins were mixed in sample buffer (pH 6.8) and incubated at 37 C for 10 minutes.
Gels were stained with InstantBlue (Expedion). The bands of the complex were excised from the gel and loaded to the wells of a
SDS-containing denaturing gel (10%).
For AUC experiments proteins (TldD, TldE or TldDE) at 0.2 mg/ml were dialyzed into 50 mM Tris$HCl pH 7.5, 100 mM NaCl.
Sedimentation equilibrium experiments were performed using a Beckman XLA-I analytical ultracentrifuge equipped with a Ti50 rotor
and absorbance optics. Samples were centrifuged at 10000 rpm at 20C and the absorbance was measured at 275 nm. Data were
fitted to a single species model using Ultrascan (Demeler, 2005).
Crystallization of TldDE
The pColA TldD-His/E co-expression plasmid was used for the large-scale production of TldD-His/E complex. Proteins were
expressed in minimal medium supplemented by Zn in order to have a >90% Zn occupancy. Briefly, BL21(DE3) Gold cells were
transformed with the pColA-TldD/E expression plasmid and 10 ml of an overnight culture in LB was used to inoculate 2 L of M9
(supplemented with 0.5% glycerol as a carbon source, 1 mg/L thiamine, 50 mM ZnCl2 and 50 mg/mL kanamycin). Cells were grown
at 37 C with shaking to OD600 = 0.8, then IPTG was added to a concentration of 0.1 mM and cultures were moved to 20 C for
overnight expression. After 20 h, cells were harvested by centrifugation at 4000 g and resuspended in lysis buffer (20 mM Tris$HCl
pH 8.0, 200 mM NaCl, 10 mM imidazole, 5% glycerol). Cells were lysed using a high-pressure cell disruptor (Constant systems Ltd)
and the lysate cleared by centrifugation (28 000 g, 45 min) and filtration (0.45 mm). An AKTA Pure FPLC was used for the subsequent
purification. Cleared lysate was loaded onto HiTrap Chelating HP 5 ml column charged with Ni2+ and washed by 20 CVs of lysis
buffer containing 20 mM imidazole before elution with 250 mM imidazole; eluted protein was immediately loaded onto a Sephacryl
S-200 HR 16/60 gel-filtration column operating in the final storage buffer (10 mM Tris$HCl pH 8, 50 mM NaCl). Peak fractions were
pooled. Protein concentration was measured with a DirectDetect IR-spectrometer (Millipore).
Crystallization experiments were performed at a protein concentration of approximately 7 mg/ml and at a temperature of 20C.
Screening was conducted by sitting-drop vapour diffusion in MRC 96-well crystallization plates (Molecular Dimensions) with a
mixture of 0.3 ml precipitant (from both commercial and in-house screens) and 0.3 ml protein solution, using either an OryxNano or
an Oryx8 crystallisation robot (Douglas Instruments). Promising conditions were optimised with the latter robot using the same crys-
tallisation format. Two conditions yielded crystals that were subsequently used for the data collections described herein. Condition 1
comprised 20 mM sodium potassium phosphate, 20% (w/v) PEG 3350, whilst condition 2 comprised 20% (w/v) PEG 1500 in 0.1 M
MMT buffer (malate-MES-Tris; Molecular Dimensions) pH 8.0; crystals from both conditions were cryoprotected in precipitant
supplemented with 20% (v/v) ethylene glycol. Once condition 2 had been established, the reproducibility of crystallisations under
these conditions was improved by microseeding. A seed stock was prepared using crystals from several drops, which were broken
up by repeated pipetting action, then pooled and transferred to an Eppendorf tube containing300 ml of the precipitant. The sample
was vortexed with a Seed Bead (Hampton Research) to break the crystals up further. Then crystallisations were set up using the
Oryx8 robot with drops comprised of 0.4 ml precipitant, 0.15 ml protein and 0.05 ml of this seed stock. This was crucial for obtaining
diffracting crystals of the TldDH262A/E and TldDE263A/E mutant protein complexes (using a wild-type seed stock).
All the ligand complexes were produced by co-crystallisation using condition 2. The ligands were prepared in 100%DMSO at con-
centrations of either 50 mM or 100 mM (for actinonin) and added to the protein to a final concentration of 2.5 mM. Thus, the final
concentration of DMSOwas either 2.5% (v/v) or 5% (v/v) depending on the ligand. Crystallisations were then set up using the seeding
procedure described above. The resultant crystals were cryoprotected in precipitant supplemented with both ethylene glycol and the
appropriate ligand.
Crystals were harvested and flash-cooled in liquid nitrogen using LithoLoops (Molecular Dimensions). The mounted crystals were
stored in Unipuck cassettes (MiTeGen) prior to transport to the Diamond Light Source (Oxfordshire, UK), where they were transferred
robotically to the goniostat on either beamline I02, I03 or I04-1 and maintained at -173 C with a Cryojet cryocooler (Oxford
Instruments). X-ray diffraction data were recorded using either a Pilatus 2M or 6M hybrid photon counting detector (Dectris), then
integrated using XDS (Kabsch, 2010) and scaled and merged using AIMLESS (Evans and Murshudov, 2013) via the XIA2 expert
system (Winter, 2010); the resultant data collection statistics are summarized in Table 1.Structure 25, 1549–1561.e1–e5, October 3, 2017 e4
Structure Solution and Refinement
The TldD/E structure was solved by molecular replacement using a dataset collected to 1.9-Å resolution from a crystal grown in the
phosphate buffer conditions. Initially, the data were processed in the orthorhombic space group P212121. However, it subsequently
became apparent that the data were pseudo-merohedrally twinned (with operator h, -k, -l) and the true space group was in fact P21
with b90. As a result, all refinement was performed with REFMAC5 (Murshudov et al., 1997) using the ‘‘amplitude based twin
refinement’’ setting and, in order to avoid bias resulting from the twinning, the R-free set of reflections was generated in the apparent
orthorhombic space group before expanding to the true monoclinic space group; this R-free set was used throughout refinement for
all datasets, which were isomorphous and similarly twinned. Molecular replacement templates were generated for TldE from Shigella
flexneri PmbA (PDB code 3TV9; 99% sequence identity), and for TldD from Thermotoga maritima PmbA (PDB code 1VL4; 23%
sequence identity) using CHAINSAW (Stein, 2008) where conserved side-chains were retained and all others were truncated to
Cb. PHASER (Mccoy et al., 2007) was able to locate two copies of the TldD/E heterodimer in the asymmetric unit (ASU), giving an
approximate solvent content of 48%. After restrained refinement in REFMAC5, removal of badly fitting regions in COOT (Emsley
and Cowtan, 2004) and further refinement, the Rwork/Rfree values were 0.386/0.420 at 1.9-Å resolution. The model phases were
then improved with PARROT (Cowtan, 2010) and used as input to completely rebuilding the model with BUCCANEER (Cowtan,
2006) which was able to fit 98.5% of the expected sequence for two copies each of TldD and TldE in the ASU, and gave much
improved Rwork/Rfree values of 0.260/0.312. The model was completed through several further iterations of model building in
COOT and restrained refinement using isotropic thermal parameters with TLS group definitions obtained from the TLSMD server
(Painter and Merritt, 2006). This model was used as the starting point for building and refinement of all the remaining structures.
Each of these had been determined to resolutions of at least 1.5 Å and thus were refined in REFMAC5 using anisotropic thermal
restraints. After rebuilding and refining the various structures, it became apparent that a point mutation had been introduced into
TldD at position 401 such that the expected Gly had additional density consistent with the presence of a side-chain. The identity
of the mutated residue was subsequently confirmed to be Asp by sequencing, which was then introduced into all the models. In
all structures, there was residual density that could be attributed to ligands derived from crystallisation or cryoprotectant solutions,
including phosphate, MES buffer, ethylene glycol and sodium ions. Several of these were modelled into the density, although those
that did not refine satisfactorily were omitted from the final models. Final statistics for all models are reported in Table 2. OmitmFobs-
dFcalc difference electron density maps were generated for bound ligands using phases from the final models without these ligands
after the application of small random shifts to the atomic coordinates, re-setting temperature factors, and re-refining to convergence.
All structural figures were generated using CCP4mg (McNicholas et al., 2011)
DATA AND SOFTWARE AVAILABILITY
Coordinates and structure factors were deposited in the RCSB Protein Data Bank with accession codes 5NJ5 for the phosphate
bound TldD/E, 5NJ9 for the TldD/E in complex with angiotensin DRVY fragment, 5NJA for the structure with a non-cleavable
angiotensin analogue (angiotensin-HPF), 5NJB for the TldD/E in complex with actinonin, 5NJC and 5NJF for the mutant
TldDE263A/E and TldDH262A/E complexes, respectively. All the used software is readily available.e5 Structure 25, 1549–1561.e1–e5, October 3, 2017
